Evidence map›Paper›PMID 11971978›Full record

ArticleMolecular and cellular biology2002

Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2.

Katia Ancelin, Michele Brunori, Serge Bauwens, Catherine-Elaine Koering, Christine Brun, Michelle Ricoul, Jean-Patrick Pommier, Laure Sabatier, Eric Gilson

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 198 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Shelterin Complex at Telomeres: Implications in Ageing.Clinical interventions in aging · 2020
    Review
  12. Article
  13. Telomere Maintenance in Pediatric Cancer.International journal of molecular sciences · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. The long and the short of TRF2 in neurogenesis.Cell cycle (Georgetown, Tex.) · 2016
    Review
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Katia AncelinLaboratoire de Biologie Moléculaire et Cellulaire, UMR5665 CNRS/ENSL, Ecole Normale Supérieure de Lyon, Lyon, France.
Michele Brunori
Serge Bauwens
Catherine-Elaine Koering
Christine Brun
Michelle Ricoul
Jean-Patrick Pommier
Laure Sabatier
Eric Gilson
École Normale Supérieure de Lyon · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the control of telomere length by the human telomeric proteins TRF1 and TRF2. To this end, we established telomerase-positive cell lines in which the targeting of these telomeric proteins to specific telomeres could be induced. We demonstrate that their targeting leads to telomere shortening. This indicates that these proteins act in cis to repress telomere elongation. Inhibition of telomerase activity by a modified oligonucleotide did not further increase the pace of telomere erosion caused by TRF1 targeting, suggesting that telomerase itself is the target of TRF1 regulation. In contrast, TRF2 targeting and telomerase inhibition have additive effects. The possibility that TRF2 can activate a telomeric degradation pathway was directly tested in human primary cells that do not express telomerase. In these cells, overexpression of full-length TRF2 leads to an increased rate of telomere shortening.

Indexed as

Escherichia coli ProteinsBacterial ProteinsCell LineChromosomesDNA-Binding ProteinsHumansIn Situ Hybridization, FluorescenceLac RepressorsNuclear ProteinsRecombinant Fusion ProteinsRepressor ProteinsTelomeraseTelomereTelomeric Repeat Binding Protein 1Telomeric Repeat Binding Protein 2TransfectionBacterial ProteinsDNA-Binding ProteinsEscherichia coli ProteinsLac RepressorsNuclear ProteinsRecombinant Fusion ProteinsRepressor ProteinsTelomeraseTelomeric Repeat Binding Protein 1Telomeric Repeat Binding Protein 2

Identifiers

PMID11971978
PMCPMC133804
OpenAlexW2154468838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.